RIGHI, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 4.527
AS - Asia 3.738
EU - Europa 2.574
AF - Africa 235
Continente sconosciuto - Info sul continente non disponibili 231
SA - Sud America 210
OC - Oceania 10
Totale 11.525
Nazione #
US - Stati Uniti d'America 4.415
CN - Cina 1.017
VN - Vietnam 974
SG - Singapore 972
GB - Regno Unito 611
IT - Italia 431
DE - Germania 316
SE - Svezia 314
HK - Hong Kong 209
IN - India 196
FR - Francia 169
BR - Brasile 143
RU - Federazione Russa 131
UA - Ucraina 111
IE - Irlanda 100
NL - Olanda 88
ZA - Sudafrica 66
CI - Costa d'Avorio 63
CA - Canada 57
FI - Finlandia 57
JP - Giappone 57
CH - Svizzera 56
KR - Corea 55
BD - Bangladesh 49
TG - Togo 49
EE - Estonia 38
BG - Bulgaria 27
ID - Indonesia 26
BE - Belgio 24
JO - Giordania 24
NG - Nigeria 24
AR - Argentina 23
TH - Thailandia 22
MX - Messico 21
PL - Polonia 20
IR - Iran 19
TR - Turchia 18
PH - Filippine 16
AT - Austria 15
TW - Taiwan 14
SA - Arabia Saudita 13
ES - Italia 12
IQ - Iraq 12
CO - Colombia 11
EC - Ecuador 11
JM - Giamaica 11
LT - Lituania 10
SC - Seychelles 10
CL - Cile 9
GR - Grecia 8
AU - Australia 7
CR - Costa Rica 7
HR - Croazia 7
LB - Libano 7
PK - Pakistan 7
PY - Paraguay 6
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
KE - Kenya 4
MY - Malesia 4
RO - Romania 4
VE - Venezuela 4
GH - Ghana 3
GT - Guatemala 3
HU - Ungheria 3
LU - Lussemburgo 3
LV - Lettonia 3
SV - El Salvador 3
AM - Armenia 2
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
CG - Congo 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
KH - Cambogia 2
MA - Marocco 2
NP - Nepal 2
PT - Portogallo 2
SI - Slovenia 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GP - Guadalupe 1
GY - Guiana 1
KW - Kuwait 1
MG - Madagascar 1
Totale 11.279
Città #
Singapore 675
Ashburn 505
Southend 501
Fairfield 341
San Jose 320
Chandler 278
Hanoi 199
Hong Kong 188
Ho Chi Minh City 179
Houston 176
Wilmington 176
Woodbridge 173
Dong Ket 154
Seattle 154
Beijing 150
Hefei 138
Princeton 135
Ann Arbor 131
Cambridge 131
Council Bluffs 125
Boardman 110
Santa Clara 107
Dublin 99
Bologna 94
New York 89
Los Angeles 69
Nanjing 69
Abidjan 63
Dallas 60
Lauterbourg 60
Westminster 53
Padova 51
Bern 50
Lomé 49
Tokyo 48
Helsinki 46
Seoul 46
Milan 45
London 43
Buffalo 41
Jacksonville 40
Haiphong 36
Bremen 35
Chicago 35
Hyderabad 35
Da Nang 33
Berlin 31
Jinan 31
Nanchang 29
Saint Petersburg 29
Shenyang 29
Frankfurt am Main 27
São Paulo 27
Sofia 26
Tianjin 25
Abeokuta 24
Brussels 24
Amman 23
Hebei 23
Guangzhou 22
Shanghai 22
Toronto 21
Phoenix 20
Jiaxing 19
Montreal 19
Hangzhou 18
Medford 18
San Diego 18
Falls Church 17
Munich 17
Mülheim 17
Redondo Beach 17
Chennai 16
Rome 16
San Francisco 16
Changsha 15
Orem 15
Zhengzhou 15
Bengaluru 14
Taizhou 14
Johannesburg 13
Atlanta 12
Can Tho 12
Ningbo 12
Warsaw 12
Jakarta 11
San Venanzo 11
Turin 11
Yubileyny 11
Amsterdam 10
Haikou 10
Modena 10
Redmond 10
Indianapolis 9
Redwood City 9
Denver 8
Florence 8
Fuzhou 8
Nuremberg 8
Philadelphia 8
Totale 7.252
Nome #
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets 311
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 274
CD103 marks a subset of human CD34+-derived langerin+ dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1 265
CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified. 261
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified 261
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia 248
IFI16 expression is related to selected transcription factors during B-cell differentiation 236
Large cell non Hodgkin’s lymphoma: what is new in the WHO classification? 232
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 229
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma 217
Aberrant expression of CD10 and BCL6 in mantle cell lymphoma 214
A 3-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma 207
Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature 203
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 202
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 201
Microenvironmental Traits of Classical Hodgkin's Lymphoma in Adolescents and Their Prognostic Impact 194
Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway. 194
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 191
SNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosis. 191
CDKN1B/P27 expression in peripheral T-cell lymphoma not otherwise specified 191
Benign TdT-positive cells in pediatric and adult lymph nodes: a potential diagnostic pitfall 189
Pathobiology of hodgkin lymphoma. 185
The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma 184
BCL10 down-regulation in peripheral T-cell lymphomas. 184
BCL10 expression in peripheral T-Cell lymphoma not otherwise specified. 182
Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples. 178
Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia 178
Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. 175
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 175
Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation 172
Familial haemophagocytic lymphohistiocytosis-related plasma cell neoplasm: a case report. 168
Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoides 166
Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified (Modern Pathology, (2020), 33, 2, (179-187), 10.1038/s41379-019-0279-8) 165
Separase overexpression defines a new subset of acute myeloma leukemia patients characterized by high CD34 and MYC levels 161
Variable activation of canonical and alternative NF-Kappa B pathway in peripheral T-Cell Lymphoma not otherwise specified. 153
Use of IGK gene rearrangement analysis for clonality assesment of lymphoid malignancies. A single center experience. 153
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 152
Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. 151
Integrated molecular profilino for the diagnosis and classification of peripheral T-cell lymphomas. 150
Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody. 149
Physiological PTEN expression in peripheral T-cell lymphoma not otherwise specified. 145
Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda. 144
Gene expression profiling of peripheral T-cell lymphoma: From bench to bedside 141
Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients 141
The role of peritumoral CD8 + /TIA1 + lymphocytes in hepatocellular carcinoma aggressiveness and recurrence after surgical resection 140
Correction: Bertuzzi et al. Microenvironmental Traits of Classical Hodgkin's Lymphoma in Adolescents and Their Prognostic Impact. Cancers 2024, 16, 4210 139
The Medium Obtained from the Culture of Hodgkin Lymphoma Cells Affects the Biophysical Characteristics of a Fibroblast Cell Model 139
Use of IGK gene rearrangement analysis for clonality assessment of lymphoid malignancies: a single center experience. 138
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified 138
Identification of Novel Cryptic Chromosomal Abnormalities in Primary Myelofibrosis by Single-Nucleotide Polymorphism Oligonucleotide Microarray. 137
TOX Expression in Mycosis Fungoides and Sezary Syndrome 134
Intracellular TCR-signaling Pathway: Novel Markers for Lymphoma Diagnosis and Potential Therapeutic Targets 134
P27 regulation in peripheral T-cell lymphoma not otherwise specified 132
Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis. 129
Tissue micro-array in haematopathology:present usage and potential. 128
Peripheral T-cell lymphoma. A still uncurable disease? 128
Proliferation centres in chronic lymphocytic leucemia: correlation with cytogenetic and clinicobiological features in 183 patients analyzed on tissue-microarrays. 121
Expression of classical NF-kappa B pathway molecules in peripheral t-cell lymphoma not otherwise specified. 120
PDGFRA activity deregulation in PTCL/NOS is a consequence of miRNA deregulation and autocrine loop sustainment. 118
Detection of LMO2 in Normal Human Tissue and Haematopoietic and Non-Haematopoietic Tumours by a Newly Developed Rabbit Monoclonal Antibody. 115
Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert's personal archive 114
Primary pulmonary T-cell lymphoproliferative disorders with a limited-stage, low proliferative index, and unusual clinical behavior: two cases of a rare occurrence 110
Large B-cell lymphoma with IRF4 rearrangement: a multi-centric study with focus on potential misleading phenotypes 105
LMO2 is a useful marker for the study and diagnosis of haematolymphoid neoplasms. 100
Three-dimensional models: a novel approach for lymphoma research 98
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial 94
Correction to: Three-dimensional models: a novel approach for lymphoma research 72
Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease 69
null 68
Immunophenotypic Profile of Adult Glioblastoma IDH-Wildtype Microenvironment: A Cohort Study 59
Primary Diffuse Large B-cell Lymphoma of the Central Nervous System: Unmet Medical Need 44
Immunohistochemical Characterization of Tumor Microenvironment Analysis in Glioblastoma IDH-Wildtype 39
Totale 11.525
Categoria #
all - tutte 32.025
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.025


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022966 0 0 62 68 103 56 21 62 35 143 237 179
2022/20231.313 161 181 72 153 104 96 31 64 233 27 105 86
2023/2024427 21 67 39 35 35 99 26 25 17 40 12 11
2024/20251.452 102 176 158 104 178 64 114 54 37 96 87 282
2025/20263.763 351 296 311 320 440 207 376 116 770 323 131 122
2026/2027630 151 189 290 0 0 0 0 0 0 0 0 0
Totale 11.525